[Preoperative screening for the hemostatic system in ENT surgery in children]

M V Drozdova1, G S Maltzeva1, E V Tyrnova1

  • 1Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech, Ministry of Health of the Russian Federation, St.-Petersburg, Russia, 190013.

Insights

Children with chronic lymphoproliferative syndrome often experience bleeding after surgery due to platelet dysfunction. Early detection and comprehensive hemostasis testing are crucial for managing this risk.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Surgical Complications

Background:

  • Postoperative bleeding is a significant concern in children with chronic lymphoproliferative syndrome.
  • Understanding the specific hemostatic abnormalities is vital for effective management.

Purpose of the Study:

  • To analyze the causes of early and late postoperative bleeding in pediatric patients with chronic lymphoproliferative syndrome.
  • To identify key hemostatic markers associated with bleeding complications.

Main Methods:

  • Retrospective analysis of 71 children (1998-2018) with chronic lymphoproliferative syndrome undergoing surgery.
  • Evaluation of platelet functional activity (aggregation), prothrombin time, activated partial thromboplastin time (APTT), and D-dimer levels.
  • Correlation of bleeding events with medication use, specifically nonsteroidal anti-inflammatory drugs.

Main Results:

  • Platelet functional disorders were observed in 83.8% of children, manifesting as impaired adrenaline-induced aggregation.
  • Late bleeding (7-10 days post-op) was linked to nonsteroidal anti-inflammatory drug use, causing platelet dysfunction.
  • Coagulation abnormalities included decreased prothrombin percent by Quick (73.5%), prolonged APTT (25%), and elevated D-dimer (1.5-2 fold) during bleeding episodes.

Conclusions:

  • Routine preoperative screening including platelet count, prothrombin time, APTT, and fibrinogen is recommended.
  • An extended hemostasis study assessing platelet adhesive, aggregative, and secretory functions is advised for patients with abnormal screening tests.
  • Proactive hemostatic assessment can mitigate the risk of postoperative bleeding in this vulnerable pediatric population.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
265
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K
Pedigree Analysis01:35

Pedigree Analysis

Overview
89.0K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.2K
Probability Laws01:49

Probability Laws

Overview
44.0K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.5K